World Class Capabilities. All from our Nation's Capital.

Bringing Biologics to the District.

Our proprietary high-efficiency manufacturing platform integrates advances in cell line technology and upstream and downstream process to achieve exponential reductions in production costs at scale. We are developing reliable and robust production systems with the potential to deliver substantially higher amounts of AAV product per batch.

Iragen is partnered with world-class, federal-grade facilities in the greater D.C. metropolitan area to support the production of Iragen products from early research through commercial launch. This includes a fully integrated process development lab, pilot production suite, and current good manufacturing (cGMP) production site, with plans to further expand the pilot production wing in 2022.